pI: 7.5651 |
Length (AA): 275 |
MW (Da): 30967 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
37 | 462 | 5wzj (A) | 216 | 640 | 11.00 | 0 | 1 | 0.8638 | 0.29 |
102 | 485 | 3k62 (A) | 171 | 564 | 32.00 | 0 | 1 | 1.1438 | -0.81 |
112 | 485 | 1m8z (A) | 841 | 1166 | 33.00 | 0 | 1 | 1.0518 | -0.63 |
118 | 485 | 3v71 (A) | 87 | 451 | 33.00 | 0 | 1 | 1.1228 | -0.7 |
228 | 498 | 5wzk (A) | 121 | 448 | 21.00 | 0.34 | 0.98 | 0.4642 | 0.74 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_171342)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_45615 | Pumilio-family RNA binding repeat containing protein |
Caenorhabditis elegans | CELE_Y73B6BL.38 | Protein PUF-11 |
Caenorhabditis elegans | CELE_Y45F10A.2 | Protein PUF-3 |
Loa Loa (eye worm) | LOAG_00888 | pumilio-family RNA binding repeat containing protein |
Onchocerca volvulus | OVOC8362 |
|
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_Y45F10A.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y45F10A.2 | Caenorhabditis elegans | sterile | wormbase |
CELE_Y73B6BL.38 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y73B6BL.38 | Caenorhabditis elegans | sterile | wormbase |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Sus scrofa | Elastase 2A | 269 aa | 26.2% | 237 aa | Compounds | References |
Rattus norvegicus | Anionic trypsin-1 | 246 aa | 21.5% | 214 aa | Compounds | References |
Bos taurus | Beta-chymotrypsin | 245 aa | 24.2% | 265 aa | Compounds | References |
Bos taurus | Alpha-chymotrypsin | 245 aa | 22.3% | 251 aa | Compounds | References |
Sus scrofa | Elastase 1 | 266 aa | 20.9% | 225 aa | Compounds | References |
Rattus norvegicus | Elastase 2A | 271 aa | 25.4% | 236 aa | Compounds | References |
Bos taurus | Trypsin I | 246 aa | 21.0% | 210 aa | Compounds | References |
Oryctolagus cuniculus | Thrombin | 235 aa | 23.4% | 231 aa | Compounds | References |
Rattus norvegicus | Trypsin II | 246 aa | 20.8% | 216 aa | Compounds | References |
Rattus norvegicus | Tryptase alpha/beta-1 | 273 aa | 20.4% | 245 aa | Compounds | References |
Sus scrofa | Pancreatic elastase | 269 aa | 26.2% | 237 aa | Compounds | References |
Sus scrofa | Trypsin | 231 aa | 21.2% | 212 aa | Compounds | References |